These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11348632)

  • 1. Novel selective hypotensive vasopressin peptides: cardiovascular and structure-activity-relationship studies.
    Chan WY; Levi R; Wo NC; Koyama M; Stoev S; Cheng LL; Manning M
    Eur J Pharmacol; 2001 May; 419(1):65-72. PubMed ID: 11348632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of potent, highly selective vasopressin hypotensive agonists.
    Stoev S; Cheng LL; Manning M; Wo NC; Szeto HH
    J Pept Sci; 2006 Sep; 12(9):592-604. PubMed ID: 16625682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity investigation of novel vasopressin hypotensive peptide agonists.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 1999 Nov; 5(11):472-90. PubMed ID: 10587312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel selective hypotensive vasopressin peptides that exhibit little or no functional interactions with known oxytocin/vasopressin receptors.
    Chan WY; Wo NC; Stoev S; Cheng LL; Manning M
    Br J Pharmacol; 1998 Oct; 125(4):803-11. PubMed ID: 9831918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel selective hypotensive vasopressin peptides. A new vasodilating vasopressin receptor?
    Chan WY; Wo NC; Stoev S; Cheng LL; Manning M
    Adv Exp Med Biol; 1998; 449():451-3. PubMed ID: 10026838
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of vasopressin in isolated rat hearts.
    Kaygisiz Z; Kabadere TE; Dernek S; Erden SH
    Indian J Physiol Pharmacol; 2001 Jan; 45(1):54-62. PubMed ID: 11211571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and design of novel vasopressin hypotensive peptide agonists.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Recept Signal Transduct Res; 1999; 19(1-4):631-44. PubMed ID: 10071789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic and cardiac effects of BMS-180448, a novel K+ATP opener, in anesthetized dogs and isolated rat hearts.
    D'Alonzo AJ; Grover GJ; Darbenzio RB; Sewter JC; Hess TA; Dzwonczyk S; Sleph PG
    Pharmacology; 1996 Feb; 52(2):101-12. PubMed ID: 8851631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of impaired cardiac function by vasopressin.
    Wilson MF; Brackett DJ; Archer LT; Hinshaw LB
    Ann Surg; 1980 Apr; 191(4):494-500. PubMed ID: 7369815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on agents with vasodilator and beta-blocking activities. I.
    Seki T; Takezaki T; Ohuchi R; Ohuyabu H; Ishimori T; Yasuda K
    Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1609-16. PubMed ID: 7954913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin.
    Isbil-Buyukcoskun N; Gulec G
    Regul Pept; 2004 Apr; 118(1-2):33-8. PubMed ID: 14759554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular pharmacology of nicardipine in animals.
    Takenaka T; Asano M; Shiono K; Shibasaki M; Inagaki O
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):7S-22S. PubMed ID: 4027153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism.
    Yalcin M; Aydin C
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):447-53. PubMed ID: 19702598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypotensive activity of calcium entry blockers in rats. Relationship with depression of alpha 2-adrenoceptor-mediated vasopressor responses.
    Van Meel JC; Timmermans PB; Van Zwieten PA
    Eur J Pharmacol; 1983 Aug; 92(1-2):27-34. PubMed ID: 6313390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog.
    Sybertz EJ; Watkins RW; Baum T; Pula K; Rivelli M
    J Pharmacol Exp Ther; 1985 Jan; 232(1):156-62. PubMed ID: 3917504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of adrenomedullin, amylin fragment 8-37 and calcitonin gene-related peptide on contractile force, heart rate and coronary perfusion pressure in isolated rat hearts.
    Kaygisiz Z; Erksap N; Uyar R; Kabadere S; Kabadere TE; Dernek S
    Acta Physiol Hung; 2003; 90(2):133-46. PubMed ID: 12903912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vasopressin and V1 receptors blockade on blood pressure and heart rate in spontaneously hypertensive rats.
    Stepniakowski K; Lapiński M; Noszczyk B; Januszewicz A; Szczepańska-Sadowska E
    Pol J Pharmacol Pharm; 1991; 43(6):487-93. PubMed ID: 1840331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of antihypertensive factor on cardiac function in spontaneously hypertensive rats].
    Wu G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Jun; 15(3):163-7. PubMed ID: 8221998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adrenomedullin on the cardiac performance and coronary flow in an isolated perfused rat heart model.
    Amatyakul S; Patumraj S; Niimi H
    Clin Hemorheol Microcirc; 2000; 23(2-4):269-75. PubMed ID: 11321450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.